nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinitapride—HTR2A—Signaling Pathways—WNT1—breast cancer	0.000291	0.000291	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—THBS1—breast cancer	0.00029	0.00029	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PLA2G4A—breast cancer	0.00029	0.00029	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CSF2—breast cancer	0.000287	0.000287	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—SRC—breast cancer	0.000284	0.000284	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FLT1—breast cancer	0.000277	0.000277	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—VEGFA—breast cancer	0.000277	0.000277	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF3—breast cancer	0.000276	0.000276	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SQSTM1—breast cancer	0.000276	0.000276	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH4—breast cancer	0.000275	0.000275	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CG—breast cancer	0.000274	0.000274	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—STAT3—breast cancer	0.000274	0.000274	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—GZMB—breast cancer	0.000274	0.000274	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—JAG1—breast cancer	0.000272	0.000272	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH3—breast cancer	0.000271	0.000271	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PARP1—breast cancer	0.000271	0.000271	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CALCA—breast cancer	0.000268	0.000268	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL2—breast cancer	0.000266	0.000266	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AGTR2—breast cancer	0.000266	0.000266	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RPS6—breast cancer	0.000265	0.000265	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTHLH—breast cancer	0.000263	0.000263	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BMP2—breast cancer	0.000263	0.000263	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF4—breast cancer	0.000263	0.000263	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MAPK3—breast cancer	0.000262	0.000262	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCR4—breast cancer	0.000262	0.000262	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL12—breast cancer	0.000262	0.000262	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PAK1—breast cancer	0.000257	0.000257	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EDNRB—breast cancer	0.000255	0.000255	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—MYC—breast cancer	0.000254	0.000254	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TGFB1—breast cancer	0.000254	0.000254	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TCF7L2—breast cancer	0.000252	0.000252	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PGR—breast cancer	0.000252	0.000252	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT2—breast cancer	0.000251	0.000251	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—THBS1—breast cancer	0.000251	0.000251	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CG—breast cancer	0.000249	0.000249	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—EGFR—breast cancer	0.000249	0.000249	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH2—breast cancer	0.000243	0.000243	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HSP90AA1—breast cancer	0.000243	0.000243	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CD—breast cancer	0.000241	0.000241	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FLT1—breast cancer	0.000239	0.000239	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF3—breast cancer	0.000238	0.000238	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SQSTM1—breast cancer	0.000238	0.000238	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CG—breast cancer	0.000237	0.000237	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AGTR1—breast cancer	0.000237	0.000237	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PRL—breast cancer	0.000237	0.000237	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—JAG1—breast cancer	0.000235	0.000235	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—KRAS—breast cancer	0.000235	0.000235	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH3—breast cancer	0.000234	0.000234	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PARP1—breast cancer	0.000234	0.000234	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ADAM10—breast cancer	0.000233	0.000233	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STK11—breast cancer	0.000233	0.000233	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CALCA—breast cancer	0.000231	0.000231	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLG—breast cancer	0.000231	0.000231	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RPS6—breast cancer	0.000229	0.000229	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT2—breast cancer	0.000228	0.000228	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF4—breast cancer	0.000227	0.000227	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF10—breast cancer	0.000227	0.000227	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCR4—breast cancer	0.000226	0.000226	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL12—breast cancer	0.000226	0.000226	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PAK1—breast cancer	0.000222	0.000222	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CD—breast cancer	0.000219	0.000219	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PDGFA—breast cancer	0.000219	0.000219	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TCF7L2—breast cancer	0.000218	0.000218	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT2—breast cancer	0.000217	0.000217	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—PIK3CA—breast cancer	0.000216	0.000216	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFBR2—breast cancer	0.000216	0.000216	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CG—breast cancer	0.000215	0.000215	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ITPR1—breast cancer	0.000212	0.000212	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT5A—breast cancer	0.000211	0.000211	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB4—breast cancer	0.000211	0.000211	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP3—breast cancer	0.000211	0.000211	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CB—breast cancer	0.00021	0.00021	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH2—breast cancer	0.00021	0.00021	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HSP90AA1—breast cancer	0.00021	0.00021	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—TP53—breast cancer	0.000209	0.000209	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CD—breast cancer	0.000208	0.000208	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AGTR1—breast cancer	0.000204	0.000204	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PRL—breast cancer	0.000204	0.000204	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SMAD4—breast cancer	0.000204	0.000204	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1R—breast cancer	0.000203	0.000203	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—CXCL8—breast cancer	0.000202	0.000202	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ADAM10—breast cancer	0.000201	0.000201	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STK11—breast cancer	0.000201	0.000201	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—HRAS—breast cancer	0.0002	0.0002	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HES1—breast cancer	0.000199	0.000199	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLG—breast cancer	0.000199	0.000199	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PLA2G4A—breast cancer	0.000198	0.000198	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NCOR1—breast cancer	0.000198	0.000198	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT2—breast cancer	0.000197	0.000197	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGF1—breast cancer	0.000196	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CSF2—breast cancer	0.000196	0.000196	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF10—breast cancer	0.000196	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—RAF1—breast cancer	0.000196	0.000196	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NRG1—breast cancer	0.000195	0.000195	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—H2AFX—breast cancer	0.000193	0.000193	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—IL2—breast cancer	0.000193	0.000193	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—E2F1—breast cancer	0.000192	0.000192	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—IL6—breast cancer	0.000191	0.000191	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CB—breast cancer	0.000191	0.000191	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CD—breast cancer	0.000189	0.000189	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PDGFA—breast cancer	0.000189	0.000189	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFBR2—breast cancer	0.000186	0.000186	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SPP1—breast cancer	0.000184	0.000184	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—CXCL8—breast cancer	0.000183	0.000183	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ITPR1—breast cancer	0.000183	0.000183	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB3—breast cancer	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT5A—breast cancer	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP3—breast cancer	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB4—breast cancer	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGFR2—breast cancer	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CB—breast cancer	0.000182	0.000182	CbGpPWpGaD
Cinitapride—HTR4—Signaling Pathways—AKT1—breast cancer	0.000176	0.000176	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SMAD4—breast cancer	0.000176	0.000176	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL2—breast cancer	0.000175	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1R—breast cancer	0.000175	0.000175	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TERT—breast cancer	0.000175	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—CXCL8—breast cancer	0.000175	0.000175	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HES1—breast cancer	0.000172	0.000172	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PLA2G4A—breast cancer	0.000171	0.000171	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NCOR1—breast cancer	0.000171	0.000171	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FGFR1—breast cancer	0.00017	0.00017	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGF1—breast cancer	0.000169	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CSF2—breast cancer	0.000169	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—RAF1—breast cancer	0.000169	0.000169	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NRG1—breast cancer	0.000168	0.000168	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HIF1A—breast cancer	0.000167	0.000167	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—H2AFX—breast cancer	0.000167	0.000167	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—IL2—breast cancer	0.000167	0.000167	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—E2F1—breast cancer	0.000166	0.000166	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CB—breast cancer	0.000165	0.000165	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—LEP—breast cancer	0.000163	0.000163	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CAV1—breast cancer	0.000162	0.000162	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KDR—breast cancer	0.00016	0.00016	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SPP1—breast cancer	0.000159	0.000159	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—CXCL8—breast cancer	0.000159	0.000159	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB3—breast cancer	0.000157	0.000157	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGFR2—breast cancer	0.000157	0.000157	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ESR1—breast cancer	0.000156	0.000156	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—FN1—breast cancer	0.000154	0.000154	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NFKBIA—breast cancer	0.000152	0.000152	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL2—breast cancer	0.000151	0.000151	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TERT—breast cancer	0.000151	0.000151	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOTCH1—breast cancer	0.000151	0.000151	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—APC—breast cancer	0.000147	0.000147	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CG—breast cancer	0.000147	0.000147	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KIT—breast cancer	0.000147	0.000147	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FGFR1—breast cancer	0.000147	0.000147	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGF—breast cancer	0.000146	0.000146	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HIF1A—breast cancer	0.000144	0.000144	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—MAPK3—breast cancer	0.000141	0.000141	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—LEP—breast cancer	0.000141	0.000141	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CAV1—breast cancer	0.00014	0.00014	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—BRAF—breast cancer	0.000138	0.000138	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KDR—breast cancer	0.000138	0.000138	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IGF1—breast cancer	0.000135	0.000135	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT2—breast cancer	0.000135	0.000135	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ESR1—breast cancer	0.000135	0.000135	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—EGFR—breast cancer	0.000134	0.000134	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—FN1—breast cancer	0.000133	0.000133	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NFKBIA—breast cancer	0.000131	0.000131	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOTCH1—breast cancer	0.00013	0.00013	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CD—breast cancer	0.000129	0.000129	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—PIK3CA—breast cancer	0.000128	0.000128	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SERPINE1—breast cancer	0.000128	0.000128	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—APC—breast cancer	0.000127	0.000127	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CG—breast cancer	0.000127	0.000127	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KIT—breast cancer	0.000127	0.000127	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—KRAS—breast cancer	0.000127	0.000127	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGF—breast cancer	0.000126	0.000126	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—NOS3—breast cancer	0.000122	0.000122	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—MAPK3—breast cancer	0.000122	0.000122	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—BRAF—breast cancer	0.00012	0.00012	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IGF1—breast cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—PIK3CA—breast cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT2—breast cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MDM2—breast cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—EGFR—breast cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RAF1—breast cancer	0.000116	0.000116	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—RELA—breast cancer	0.000115	0.000115	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—ERBB2—breast cancer	0.000114	0.000114	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CB—breast cancer	0.000113	0.000113	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MTOR—breast cancer	0.000113	0.000113	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CD—breast cancer	0.000112	0.000112	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—PIK3CA—breast cancer	0.000111	0.000111	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SERPINE1—breast cancer	0.000111	0.000111	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—KRAS—breast cancer	0.000109	0.000109	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CXCL8—breast cancer	0.000108	0.000108	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—HRAS—breast cancer	0.000108	0.000108	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN1B—breast cancer	0.000106	0.000106	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—NOS3—breast cancer	0.000106	0.000106	CbGpPWpGaD
Cinitapride—HTR1A—GPCR downstream signaling—AKT1—breast cancer	0.000105	0.000105	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CASP3—breast cancer	0.000104	0.000104	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL2—breast cancer	0.000104	0.000104	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—IL6—breast cancer	0.000103	0.000103	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CCND1—breast cancer	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—JUN—breast cancer	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—PIK3CA—breast cancer	0.000101	0.000101	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MDM2—breast cancer	0.0001	0.0001	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CTNNB1—breast cancer	0.0001	0.0001	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RAF1—breast cancer	9.98e-05	9.98e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—RELA—breast cancer	9.94e-05	9.94e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—ERBB2—breast cancer	9.87e-05	9.87e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MMP9—breast cancer	9.8e-05	9.8e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—CDKN1A—breast cancer	9.77e-05	9.77e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PTEN—breast cancer	9.75e-05	9.75e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MTOR—breast cancer	9.74e-05	9.74e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CB—breast cancer	9.74e-05	9.74e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK8—breast cancer	9.53e-05	9.53e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling by GPCR—AKT1—breast cancer	9.51e-05	9.51e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CXCL8—breast cancer	9.36e-05	9.36e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—HRAS—breast cancer	9.3e-05	9.3e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN1B—breast cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Cinitapride—HTR2A—GPCR downstream signaling—AKT1—breast cancer	9.05e-05	9.05e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—SRC—breast cancer	9.04e-05	9.04e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CASP3—breast cancer	8.96e-05	8.96e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL2—breast cancer	8.95e-05	8.95e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—IL6—breast cancer	8.9e-05	8.9e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—VEGFA—breast cancer	8.8e-05	8.8e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CCND1—breast cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—STAT3—breast cancer	8.72e-05	8.72e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—JUN—breast cancer	8.71e-05	8.71e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CTNNB1—breast cancer	8.64e-05	8.64e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MMP9—breast cancer	8.47e-05	8.47e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—CDKN1A—breast cancer	8.44e-05	8.44e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PTEN—breast cancer	8.42e-05	8.42e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MAPK3—breast cancer	8.33e-05	8.33e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK8—breast cancer	8.24e-05	8.24e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling by GPCR—AKT1—breast cancer	8.21e-05	8.21e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—MYC—breast cancer	8.1e-05	8.1e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TGFB1—breast cancer	8.08e-05	8.08e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—EGFR—breast cancer	7.92e-05	7.92e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—SRC—breast cancer	7.81e-05	7.81e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—VEGFA—breast cancer	7.61e-05	7.61e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—STAT3—breast cancer	7.53e-05	7.53e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—KRAS—breast cancer	7.48e-05	7.48e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MAPK3—breast cancer	7.19e-05	7.19e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—MYC—breast cancer	7e-05	7e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TGFB1—breast cancer	6.98e-05	6.98e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—PIK3CA—breast cancer	6.88e-05	6.88e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—EGFR—breast cancer	6.84e-05	6.84e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—TP53—breast cancer	6.65e-05	6.65e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—KRAS—breast cancer	6.47e-05	6.47e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—HRAS—breast cancer	6.36e-05	6.36e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—IL6—breast cancer	6.09e-05	6.09e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—PIK3CA—breast cancer	5.94e-05	5.94e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—TP53—breast cancer	5.75e-05	5.75e-05	CbGpPWpGaD
Cinitapride—HTR1A—Signaling Pathways—AKT1—breast cancer	5.62e-05	5.62e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—HRAS—breast cancer	5.5e-05	5.5e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—IL6—breast cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Cinitapride—HTR2A—Signaling Pathways—AKT1—breast cancer	4.85e-05	4.85e-05	CbGpPWpGaD
